NCT02525718View on ClinicalTrials.gov

Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

March 31, 2017

Conditions
Breast Cancer
Interventions
DRUG

Saline

If randomized to this arm, subjects will receive an intraoperative injection of saline. (2.5 mg/ml)

DRUG

0.25 % bupivacaine (2.5 mg/ml) w/ 1:100,000 epinephrine & 4 mg dexamethasone

"If randomized to this arm, subjects will receive a selective block with a local anesthetic solution containing 0.25 % bupivacaine.~(2.5 mg/ml) with 1:100,000 epinephrine and 4 mg dexamethasone intraoperatively."

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT02525718 - Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction | Biotech Hunter | Biotech Hunter